The Global Digital Vaccine Market Size is valued at 1.61 billion in 2023 and is predicted to reach 3.73 billion by the year 2031 at a 11.25% CAGR during the forecast period for 2024-2031.
Digital Vaccines are a subset of digital therapeutics. Digital vaccines deploy applications on smartphones, tablets, and other similar devices for neurocognitive training to promote positive human behavior. The breakthrough in vaccine creation resulted recently with digital vaccines, which allowed for the developing antigens to utilize their molecular structure, commonly in conjunction with antibodies and made it feasible to create synthetic genes and deliver them as mRNAs.
Digital therapeutics rapid technological development is accelerating the digital vaccine market expansion. The industry is further escalating due to advancements in digital vaccines like the Internet of Things (IoT), wearable technology, metaverse platforms, and Augmented Reality (AR/VR).
Digital vaccine Market demand is anticipated to be impacted by factors such as the growing population, increased research and developments activities, rise in the number of individuals suffering from different diseases, improved collaboration with progressive governments, and acceptable funders and investors.
Several other vital global factors impacting the growth of the digital vaccine market are data privacy laws and the growing use of digital vaccinations in the healthcare industry. Another significant factor affecting the digital vaccine market growth rate is the rising healthcare expense, which helps build its infrastructure.
The digital vaccine market is segmented on the device used and applications. Based on the device used, the market is segmented into smartphones, tablets and others. Based on applications, the digital vaccine market is segmented into covid-19, influenza, diabetes, cardiovascular diseases, hypertension and Others.
The market's leading segment is smartphone. Increased adoption of premium smartphone designs, high disposable income, strong internet connectivity use of mobile internet, and an increase in population technological approach are the key drivers of smartphone use. Through ongoing behavioral interventions, smartphone developments in digital vaccinations help deliver many medical diseases at a much-reduced rate.
Infectious Diseases grabbed the highest revenue share and anticipated to continue to hold that position during the forecast time. Increased incidence of infectious diseases, such as hepatitis, influenza, COVID-19, and human immunodeficiency virus, is the primary factor driving the global market expansion. According to mortality surveillance statistics from the National Center for Health Statistics (NCHS) that were available on April 6, 2023, pneumonia, influenza, and/or COVID-19 were responsible for 7.9% of fatalities that occurred during the week ending April 1, 2023 (PIC).
The prevalence of infectious diseases in both developed and developing regions will positively affect market growth. The occurrence of Covid-19 pandemic emerged as a significant market growth factor.
Although typically, vaccine research takes years to complete the necessary testing, governments and medical agencies hastened vaccine development in response to the outbreak's severity. The World Health Organization (WHO) and various government regulatory agencies have launched several initiatives due to the quick advancement of vaccine research.
The North American digital vaccine market is anticipated to register the highest market share, and this is because the region has essential key players and developed healthcare infrastructure. Regional development is anticipated to be fueled by a rising patient base, increased healthcare investment, and government assistance. In addition, Asia Pacific is projected to grow rapidly in the global digital vaccine market because more infectious diseases are emerging, and governments are supporting immunization.
|
Report Attribute |
Specifications |
|
Market size value in 2023 |
USD 1.61 Bn |
|
Revenue forecast in 2031 |
USD 3.73 Bn |
|
Growth rate CAGR |
CAGR of 11.25% from 2024 to 2031 |
|
Quantitative units |
Representation of revenue in US$ Million, and CAGR from 2024 to 2031 |
|
Historic Year |
2019 to 2023 |
|
Forecast Year |
2024-2031 |
|
Report coverage |
The forecast of revenue, the position of the company, the competitive market statistics, growth prospects, and trends |
|
Segments covered |
Heat Source, Component, Plant Type, And Application |
|
Regional scope |
North America; Europe; Asia Pacific; Latin America; Middle East & Africa |
|
Country scope |
U.S.; Canada; U.K.; Germany; China; India; Japan; Brazil; Mexico; The UK; France; Italy; Spain; Japan; South Korea; Southeast Asia; South Korea |
|
Competitive Landscape |
FriendsLearn, Inc., Klein Buendel, Inc., Sanofi S.A., Evidation Health, Inc., and Atos. |
|
Customization scope |
Free customization report with the procurement of the report, Modifications to the regional and segment scope. Particular Geographic competitive landscape. |
|
Pricing and available payment methods |
Explore pricing alternatives that are customized to your particular study requirements. |
Chapter 1. Methodology and Scope
1.1. Research Methodology
1.2. Research Scope & Assumptions
Chapter 2. Executive Summary
Chapter 3. Global Digital Vaccine Market Snapshot
Chapter 4. Global Digital Vaccine Market Variables, Trends & Scope
4.1. Market Segmentation & Scope
4.2. Drivers
4.3. Challenges
4.4. Trends
4.5. Investment and Funding Analysis
4.6. Industry Analysis – Porter’s Five Forces Analysis
4.7. Competitive Landscape & Market Share Analysis
4.8. Impact of Covid-19 Analysis
Chapter 5. Market Segmentation 1: by Device Estimates & Trend Analysis
5.1. by Device & Market Share, 2023 & 2031
5.2. Market Size (Value (US$ Mn) & Forecasts and Trend Analyses, 2019 to 2031 for the following by Device:
5.2.1. Smartphones
5.2.2. Tablets
5.2.3. Others
Chapter 6. Market Segmentation 2: by Application Estimates & Trend Analysis
6.1. by Application & Market Share, 2023 & 2031
6.2. Market Size (Value (US$ Mn) & Forecasts and Trend Analyses, 2019 to 2031 for the following by Application:
6.2.1. Hospitals
6.2.2. Ambulatory Care Centers
6.2.3. Specialty Clinics
6.2.4. Others
Chapter 7. Digital Vaccine Market Segmentation 3: Regional Estimates & Trend Analysis
7.1. North America
7.1.1. North America Digital Vaccine Market Revenue (US$ Million) Estimates and Forecasts by Device, 2023-2031
7.1.2. North America Digital Vaccine Market Revenue (US$ Million) Estimates and Forecasts by Application, 2023-2031
7.1.3. North America Digital Vaccine Market Revenue (US$ Million) Estimates and Forecasts by country, 2023-2031
7.2. Europe
7.2.1. Europe Digital Vaccine Market Revenue (US$ Million) Estimates and Forecasts by Device, 2023-2031
7.2.2. Europe Digital Vaccine Market Revenue (US$ Million) Estimates and Forecasts by Application, 2023-2031
7.2.3. Europe Digital Vaccine Market Revenue (US$ Million) Estimates and Forecasts by country, 2023-2031
7.3. Asia Pacific
7.3.1. Asia Pacific Digital Vaccine Market Revenue (US$ Million) Estimates and Forecasts by Device, 2023-2031
7.3.2. Asia Pacific Digital Vaccine Market Revenue (US$ Million) Estimates and Forecasts by Application, 2023-2031
7.3.3. Asia Pacific Digital Vaccine Market Revenue (US$ Million) Estimates and Forecasts by country, 2023-2031
7.4. Latin America
7.4.1. Latin America Digital Vaccine Market Revenue (US$ Million) Estimates and Forecasts by Device, 2023-2031
7.4.2. Latin America Digital Vaccine Market Revenue (US$ Million) Estimates and Forecasts by Application, 2023-2031
7.4.3. Latin America Digital Vaccine Market Revenue (US$ Million) Estimates and Forecasts by country, 2023-2031
7.5. Middle East & Africa
7.5.1. Middle East & Africa Digital Vaccine Market Revenue (US$ Million) Estimates and Forecasts by Device, 2023-2031
7.5.2. Middle East & Africa Digital Vaccine Market Revenue (US$ Million) Estimates and Forecasts by Application, 2023-2031
7.5.3. Middle East & Africa Digital Vaccine Market Revenue (US$ Million) Estimates and Forecasts by country, 2023-2031
Chapter 8. Competitive Landscape
8.1. Major Mergers and Acquisitions/Strategic Alliances
8.2. Company Profiles
8.2.1. FriendsLearn Inc.,
8.2.2. Klein Buendel Inc.
8.2.3. Sanofi S.A
8.2.4. Evidation Health
8.2.5. Atos SE
8.2.6. oVRcome
8.2.7. Other Prominent Players
Segmentation of Digital Vaccine Market-
Digital Vaccine Market By Device Used:
Digital Vaccine Market By Application:
Digital Vaccine Market By Region-
North America-
Europe-
Asia-Pacific-
Latin America-
Middle East & Africa-
InsightAce Analytic follows a standard and comprehensive market research methodology focused on offering the most accurate and precise market insights. The methods followed for all our market research studies include three significant steps – primary research, secondary research, and data modeling and analysis - to derive the current market size and forecast it over the forecast period. In this study, these three steps were used iteratively to generate valid data points (minimum deviation), which were cross-validated through multiple approaches mentioned below in the data modeling section.
Through secondary research methods, information on the market under study, its peer, and the parent market was collected. This information was then entered into data models. The resulted data points and insights were then validated by primary participants.
Based on additional insights from these primary participants, more directional efforts were put into doing secondary research and optimize data models. This process was repeated till all data models used in the study produced similar results (with minimum deviation). This way, this iterative process was able to generate the most accurate market numbers and qualitative insights.
Secondary research
The secondary research sources that are typically mentioned to include, but are not limited to:
The paid sources for secondary research like Factiva, OneSource, Hoovers, and Statista
Primary Research:
Primary research involves telephonic interviews, e-mail interactions, as well as face-to-face interviews for each market, category, segment, and subsegment across geographies
The contributors who typically take part in such a course include, but are not limited to:
Data Modeling and Analysis:
In the iterative process (mentioned above), data models received inputs from primary as well as secondary sources. But analysts working on these models were the key. They used their extensive knowledge and experience about industry and topic to make changes and fine-tuning these models as per the product/service under study.
The standard data models used while studying this market were the top-down and bottom-up approaches and the company shares analysis model. However, other methods were also used along with these – which were specific to the industry and product/service under study.
To know more about the research methodology used for this study, kindly contact us/click here.
